Topline results of Phase 2 Long Covid trial do not show evidence of superior efficacy of BC 007 over placebo arm
Berlin, Germany, 13 November 2024Berlin Cures AG informs about the status of topline results of BC 007 in Long Covid from the randomized and double-blind Phase 2 trial, which has been conducted by its affiliate Berlin Cures GmbH.
No comments:
Post a Comment